Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-000425

Chief Financial Officer gave up 2,536 shares (to pay taxes)

  • Chief Financial Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Balthaser Kevin · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-01 Exercise or conversion : show line 1 in the form +7,500 22,961 D
2024-01-01 Shares withheld for taxes : show line 2 in the form −2,536 $1.05 $2,663 20,425 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,500 22,500 D
Loading xslF345X05/doc4.xml…